454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938.

To analyze the global microbial composition, using large-scale DNA sequencing of 16 S rRNA genes, in faecal samples from colicky infants given L. reuteri DSM 17938 or placebo.Twenty-nine colicky infants (age 10-60 days) were enrolled and randomly assigned to receive either Lactobacillus reuteri (10(...

Full description

Bibliographic Details
Main Authors: Stefan Roos, Johan Dicksved, Valentina Tarasco, Emanuela Locatelli, Fulvio Ricceri, Ulf Grandin, Francesco Savino
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3585302?pdf=render
id doaj-4794b69ae81a420ba09a73fdcad4a7de
record_format Article
spelling doaj-4794b69ae81a420ba09a73fdcad4a7de2020-11-25T00:08:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0182e5671010.1371/journal.pone.0056710454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938.Stefan RoosJohan DicksvedValentina TarascoEmanuela LocatelliFulvio RicceriUlf GrandinFrancesco SavinoTo analyze the global microbial composition, using large-scale DNA sequencing of 16 S rRNA genes, in faecal samples from colicky infants given L. reuteri DSM 17938 or placebo.Twenty-nine colicky infants (age 10-60 days) were enrolled and randomly assigned to receive either Lactobacillus reuteri (10(8) cfu) or a placebo once daily for 21 days. Responders were defined as subjects with a decrease of 50% in daily crying time at day 21 compared with the starting point. The microbiota of faecal samples from day 1 and 21 were analyzed using 454 pyrosequencing. The primers: Bakt_341F and Bakt_805R, complemented with 454 adapters and sample specific barcodes were used for PCR amplification of the 16 S rRNA genes. The structure of the data was explored by using permutational multivariate analysis of variance and effects of different variables were visualized with ordination analysis.The infants' faecal microbiota were composed of Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes as the four main phyla. The composition of the microbiota in infants with colic had very high inter-individual variability with Firmicutes/Bacteroidetes ratios varying from 4000 to 0.025. On an individual basis, the microbiota was, however, relatively stable over time. Treatment with L. reuteri DSM 17938 did not change the global composition of the microbiota, but when comparing responders with non-responders the group responders had an increased relative abundance of the phyla Bacteroidetes and genus Bacteroides at day 21 compared with day 0. Furthermore, the phyla composition of the infants at day 21 could be divided into three enterotype groups, dominated by Firmicutes, Bacteroidetes, and Actinobacteria, respectively.L. reuteri DSM 17938 did not affect the global composition of the microbiota. However, the increase of Bacteroidetes in the responder infants indicated that a decrease in colicky symptoms was linked to changes of the microbiota.ClinicalTrials.gov NCT00893711.http://europepmc.org/articles/PMC3585302?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Stefan Roos
Johan Dicksved
Valentina Tarasco
Emanuela Locatelli
Fulvio Ricceri
Ulf Grandin
Francesco Savino
spellingShingle Stefan Roos
Johan Dicksved
Valentina Tarasco
Emanuela Locatelli
Fulvio Ricceri
Ulf Grandin
Francesco Savino
454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938.
PLoS ONE
author_facet Stefan Roos
Johan Dicksved
Valentina Tarasco
Emanuela Locatelli
Fulvio Ricceri
Ulf Grandin
Francesco Savino
author_sort Stefan Roos
title 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938.
title_short 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938.
title_full 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938.
title_fullStr 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938.
title_full_unstemmed 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938.
title_sort 454 pyrosequencing analysis on faecal samples from a randomized dbpc trial of colicky infants treated with lactobacillus reuteri dsm 17938.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description To analyze the global microbial composition, using large-scale DNA sequencing of 16 S rRNA genes, in faecal samples from colicky infants given L. reuteri DSM 17938 or placebo.Twenty-nine colicky infants (age 10-60 days) were enrolled and randomly assigned to receive either Lactobacillus reuteri (10(8) cfu) or a placebo once daily for 21 days. Responders were defined as subjects with a decrease of 50% in daily crying time at day 21 compared with the starting point. The microbiota of faecal samples from day 1 and 21 were analyzed using 454 pyrosequencing. The primers: Bakt_341F and Bakt_805R, complemented with 454 adapters and sample specific barcodes were used for PCR amplification of the 16 S rRNA genes. The structure of the data was explored by using permutational multivariate analysis of variance and effects of different variables were visualized with ordination analysis.The infants' faecal microbiota were composed of Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes as the four main phyla. The composition of the microbiota in infants with colic had very high inter-individual variability with Firmicutes/Bacteroidetes ratios varying from 4000 to 0.025. On an individual basis, the microbiota was, however, relatively stable over time. Treatment with L. reuteri DSM 17938 did not change the global composition of the microbiota, but when comparing responders with non-responders the group responders had an increased relative abundance of the phyla Bacteroidetes and genus Bacteroides at day 21 compared with day 0. Furthermore, the phyla composition of the infants at day 21 could be divided into three enterotype groups, dominated by Firmicutes, Bacteroidetes, and Actinobacteria, respectively.L. reuteri DSM 17938 did not affect the global composition of the microbiota. However, the increase of Bacteroidetes in the responder infants indicated that a decrease in colicky symptoms was linked to changes of the microbiota.ClinicalTrials.gov NCT00893711.
url http://europepmc.org/articles/PMC3585302?pdf=render
work_keys_str_mv AT stefanroos 454pyrosequencinganalysisonfaecalsamplesfromarandomizeddbpctrialofcolickyinfantstreatedwithlactobacillusreuteridsm17938
AT johandicksved 454pyrosequencinganalysisonfaecalsamplesfromarandomizeddbpctrialofcolickyinfantstreatedwithlactobacillusreuteridsm17938
AT valentinatarasco 454pyrosequencinganalysisonfaecalsamplesfromarandomizeddbpctrialofcolickyinfantstreatedwithlactobacillusreuteridsm17938
AT emanuelalocatelli 454pyrosequencinganalysisonfaecalsamplesfromarandomizeddbpctrialofcolickyinfantstreatedwithlactobacillusreuteridsm17938
AT fulvioricceri 454pyrosequencinganalysisonfaecalsamplesfromarandomizeddbpctrialofcolickyinfantstreatedwithlactobacillusreuteridsm17938
AT ulfgrandin 454pyrosequencinganalysisonfaecalsamplesfromarandomizeddbpctrialofcolickyinfantstreatedwithlactobacillusreuteridsm17938
AT francescosavino 454pyrosequencinganalysisonfaecalsamplesfromarandomizeddbpctrialofcolickyinfantstreatedwithlactobacillusreuteridsm17938
_version_ 1725415467459280896